This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, F.-L. Articles by Amin, S. G. Search for Related Content PubMed PubMed Citation Articles by Chung, F.-L. Articles by Amin, S. G.

Inhibition of Lung Carcinogenesis by Black Tea in Fischer Rats Treated with a Tobacco-specific Carcinogen: Caffeine as an Important Constituent¹

Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595 [F-L. C., M. W., A. R., M. J. I., J. C. R., B. P., S. G. A.]; and Department of Food Science, Cook College, Rutgers University, New Brunswick, New Jersey 08903 [C-T. H.]

Here, we examined the effect of black tea and caffeine on lung tumorigenesis in F344 rats induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in a 2-year bioassay. NNK was administered s.c. at a dose of 1.5 mg/kg body weight three times weekly for 20 weeks. Animals were given either black tea as drinking water at concentrations of 2%, 1%, or 0.5%, or caffeine in drinking water at concentrations identical to those in 2% and 0.5% tea infusions for 22 weeks. The treatment period began 1 week before and ended 1 week after the NNK administration. The animals were sacrificed on week 101 for the examination of tumors in target organs, including lung, liver, nasal cavity, and other major organs. The NNK-treated group, given 2% black tea, showed a significant reduction of the total lung tumor (adenomas, adenocarcinomas, and adenosquamous carcinomas) incidence from 47% to 19%, whereas the group given 1% and 0.5% black tea showed no change. The 2% tea also reduced liver tumor incidence induced by NNK from 34% in the group given only deionized water to 12%. The tumor incidence in the nasal cavity, however, was not affected by either black tea or caffeine at any of the concentrations tested. The most unexpected finding was the remarkable reduction of the lung tumor incidence, from 47% to 10%, in the group treated with 680 ppm caffeine, a concentration equivalent to that found in the 2% tea. This incidence is comparable to background levels seen in the control group. This study demonstrated for the first time in a 2-year lifetime bioassay that black tea protects against lung tumorigenesis in F344 rats, and this effect appears to be attributed, to a significant extent, to caffeine as an active ingredient of tea.

¹ This work was supported by grants from The Tea Trade Health Research association and by National Cancer Institute Grant CA46535. This is paper no. 28 in the series "Dietary Inhibitors of Chemical Carcinogenesis."

² To whom requests for reprints should be addressed, at American Health Foundation, 1 Dana Road, Valhalla, NY 10595, Phone: (914) 789-7161; Fax: (914) 592-6317; E-mail: chungahf@aol.com.

Received 5/ 8/98. Accepted 7/27/98.

This article has been cited by other articles:

				A. M. Bode and Z. Dong Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail Cancer Prevention Research, June 1, 2009; 2(6): 514 - 517. [Full Text] [PDF]

				D. J. Castro, Z. Yu, C. V. Lohr, C. B. Pereira, J. N. Giovanini, K. A. Fischer, G. A. Orner, R. H. Dashwood, and D. E. Williams Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine Carcinogenesis, August 1, 2008; 29(8): 1581 - 1586. [Abstract] [Full Text] [PDF]

				G. Lu, J. Liao, G. Yang, K. R. Reuhl, X. Hao, and C. S. Yang Inhibition of Adenoma Progression to Adenocarcinoma in a 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Lung Tumorigenesis Model in A/J Mice by Tea Polyphenols and Caffeine Cancer Res., December 1, 2006; 66(23): 11494 - 11501. [Abstract] [Full Text] [PDF]

				F.-L. Chung, J. Schwartz, C. R. Herzog, and Y.-M. Yang Tea and Cancer Prevention: Studies in Animals and Humans J. Nutr., October 1, 2003; 133(10): 3268S - 3274. [Abstract] [Full Text] [PDF]

				K. M.W. Pisters, R. A. Newman, B. Coldman, D. M. Shin, F. R. Khuri, W. K. Hong, B. S. Glisson, and J. S. Lee Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors J. Clin. Oncol., March 15, 2001; 19(6): 1830 - 1838. [Abstract] [Full Text] [PDF]

				G Lopez-Abente and A Escolar Tobacco consumption and bladder cancer in non-coffee drinkers J Epidemiol Community Health, January 1, 2001; 55(1): 68 - 70. [Full Text] [PDF]

				M. d.M.v. Pressentin, M. Chen, and J. B. Guttenplan Mutagenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosonornicotine in lacZ upper aerodigestive tissue and liver and inhibition by green tea Carcinogenesis, January 1, 2001; 22(1): 203 - 206. [Abstract] [Full Text] [PDF]

				H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF]

				C. S. Yang, J. Y. Chung, G.-y. Yang, S. K. Chhabra, and M.-J. Lee Tea and Tea Polyphenols in Cancer Prevention J. Nutr., February 1, 2000; 130(2): 472 - 472. [Abstract] [Full Text]

				D. A. August, J. Landau, D. Caputo, J. Hong, M.-J. Lee, and C. S. Yang Ingestion of Green Tea Rapidly Decreases Prostaglandin E2 Levels in Rectal Mucosa in Humans Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 709 - 713. [Abstract] [Full Text]

				A. S. Tam, J. F. Foley, T. R. Devereux, R. R. Maronpot, and T. E. Massey High Frequency and Heterogeneous Distribution of p53 Mutations in Aflatoxin B1-induced Mouse Lung Tumors Cancer Res., August 1, 1999; 59(15): 3634 - 3640. [Abstract] [Full Text] [PDF]